Results 141 to 150 of about 39,287 (277)

Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen   +7 more
wiley   +1 more source

TEXTBOOK OF FORENSIC PHARMACY: PHARMACEUTICAL JURISPRUDENCE

open access: yesJournal of Drug Delivery and Therapeutics, 2013
B Chourasia, R Chaurasia
openaire   +2 more sources

Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024

open access: yesAddiction, EarlyView.
Abstract Background and aims Nitazenes are a novel subclass of synthetic opioids that have been increasingly implicated in the United States (US) overdose crisis. Despite their growing presence in the illicit drug supply, national trends have not been systematically evaluated.
David T. Zhu   +3 more
wiley   +1 more source

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

open access: yesAddiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski   +2 more
wiley   +1 more source

Toxicokinetic modelling of the synthetic cannabinoid 5F‐MDMB‐P7AICA and its main metabolite in pigs following pulmonary administration

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Since their emergence on the drug market, synthetic cannabinoids (SC) are still gaining increasing importance in forensic toxicology. The representatives of the so‐called new psychoactive substances have in common that they have not undergone preclinical safety studies. Hence, knowledge on toxicokinetic (TK) data is sparse.
Adrian A. Doerr   +10 more
wiley   +1 more source

Response to Authors' reply

open access: yes
Journal of Forensic Sciences, EarlyView.
Aaron Olson
wiley   +1 more source

The DNA/RNA autophagy protein SIDT2 as a novel neuropathological hallmark in Huntington disease

open access: yesBrain Pathology, EarlyView.
SIDT2‐immunoreactive inclusions are observed in the striatum, cerebral cortex, and hypothalamus in HD cases with different Vonsattel grades, and the frequency of SIDT2‐immunoreactive inclusions is associated with longer CAG repeats in the huntingtin gene.
Sanaz Gabery   +17 more
wiley   +1 more source

Health Beliefs and Obesity Bias as Determinants of Attitudes Toward the Rising Tides of GLP-1 Medications: Mounjaro and Ozempic

open access: yesDiabetes, Metabolic Syndrome and Obesity
Kholoud Al-Mahzoum,1 Doaa H Abdelaziz,2,3 Fajer Alenezi,4 Jouza Almutairi,4 Mohammad Khaled Alsubaiei,4 Abdullah Bader Alharbi,4 Sarah Al-Rawi,4 Shahad Al-Rawi,4 Fatemah Faisal Bousheheri,4 Ahmad Hameed Alhajri,4 Saif Nasser Alajmi,4 Mohammed Sallam,5 ...
Al-Mahzoum K   +14 more
doaj  

Home - About - Disclaimer - Privacy